| 000 | 01721 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250516011438.0 | ||
| 264 | 0 | _c20110404 | |
| 008 | 201104s 0 0 eng d | ||
| 022 | _a1557-3265 | ||
| 024 | 7 |
_a10.1158/1078-0432.CCR-10-2658 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCarson, William E | |
| 245 | 0 | 0 |
_aBraking bad: blockade of inhibitory pathways improves interleukin-15 therapy. _h[electronic resource] |
| 260 |
_bClinical cancer research : an official journal of the American Association for Cancer Research _cDec 2010 |
||
| 300 |
_a5917-9 p. _bdigital |
||
| 500 | _aPublication Type: Comment; Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntibodies, Neutralizing _xadministration & dosage |
| 650 | 0 | 4 |
_aAntigens, CD _ximmunology |
| 650 | 0 | 4 |
_aAntigens, Differentiation _ximmunology |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 | _aCTLA-4 Antigen |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 | _aDrug Evaluation, Preclinical |
| 650 | 0 | 4 | _aDrug Synergism |
| 650 | 0 | 4 |
_aImmune Tolerance _xdrug effects |
| 650 | 0 | 4 |
_aImmunotherapy _xmethods |
| 650 | 0 | 4 |
_aInterleukin-15 _xtherapeutic use |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aModels, Biological |
| 650 | 0 | 4 | _aNeoplasm Metastasis |
| 650 | 0 | 4 |
_aNeoplasms _xdrug therapy |
| 650 | 0 | 4 | _aProgrammed Cell Death 1 Receptor |
| 650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
| 650 | 0 | 4 | _aTreatment Outcome |
| 773 | 0 |
_tClinical cancer research : an official journal of the American Association for Cancer Research _gvol. 16 _gno. 24 _gp. 5917-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1158/1078-0432.CCR-10-2658 _zAvailable from publisher's website |
| 999 |
_c20336840 _d20336840 |
||